Get started
Author

Miri Zektser

Observed names: M Zektser, M. Zektser, Zektser M., Zektser Miri
ORCID: 0000-0001-6228-9135
Observed ORCID: 0000-0001-6228-9135
OpenAlex ID: A5070086014
Comparison of Diabetic Ketoacidosis in Patients With Type-1 and Type-2 Diabetes Mellitus
2013 · Leonid Barski, Roman Nevzorov, et al. · The American Journal of the Medical Sciences · 102
Diabetic ketoacidosis: clinical characteristics, precipitating factors and outcomes of care.
2012 · Leonid Barski, Roman Nevzorov, et al. · PubMed · 83
Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study
2022 · Tamir Shragai, Hila Magen, et al. · British Journal of Haematology · 46
PDF
Venetoclax is safe and efficacious in relapsed/refractory AML
2020 · Chezi Ganzel, Ron Ram, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 37
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience
2020 · Yafit Segman, Elena Ribakovsky, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 36
Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice
2021 · Arie Apel, Yakir Moshe, et al. · American Journal of Hematology · 31
Safety and efficacy of blinatumomab: a real world data
2020 · Arie Apel, Yishai Ofran, et al. · Annals of Hematology · 30
Daratumumab for relapsed AL amyloidosis—When cumulative real‐world data precedes clinical trials: A multisite study and systematic literature review
2020 · Tamir Shragai, Moshe Gatt, et al. · European Journal Of Haematology · 27
Gender-Related Differences in Clinical Characteristics and Outcomes in Patients with Diabetic Ketoacidosis
2011 · Leonid Barski, Ilana Harman-Boehm, et al. · Gender Medicine · 25
A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma
2023 · Osnat Bairey, Alisa Taliansky, et al. · Cancer · 24
PDF
New approaches to the use of insulin in patients with diabetic ketoacidosis
2013 · Leonid Barski, Louise Kezerle, et al. · European Journal of Internal Medicine · 23
Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy
2021 · Liza Barki-Harrington, Orna Baron-Epel, et al. · Palliative Medicine · 18
Real‐world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco‐Israeli collaborative myeloma working group
2020 · Eirini Katodritou, Efstathios Kastritis, et al. · American Journal of Hematology · 18
PDF
Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma
2022 · Muhammed Iraqi, Avishay Edri, et al. · International Journal of Molecular Sciences · 17
PDF
Single Cell RNA Sequencing in Patients Enrolled in a Selinexor Clinical Trial Reveals Overexpression of Alternative Nuclear Export Pathways Associated with Resistance to Selinexor in Refractory Multiple Myeloma
2021 · Yael C Cohen, Mor Zada, et al. · Blood · 10
Large hemorrhagic pericardial effusion.
2012 · Leonid Barski, Leah Shalev, et al. · PubMed · 10
A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma—Outcomes indicative for improved survival overtime
2023 · Osnat Bairey, Eyal Lebel, et al. · Hematological Oncology · 7
PDF
Effectiveness of Inferior Vena Cava Filters without Anticoagulation Therapy for Prophylaxis of Recurrent Pulmonary Embolism
2016 · Miri Zektser, Carmi Bartal, et al. · Rambam Maimonides Medical Journal · 7
PDF
HLA-E[pHLA-G] complex–specific monoclonal antibody enhancing NK activity in multiple myeloma
2025 · Muhammad Abu Ahmad, Olga Radinsky, et al. · Blood Advances · 4
PDF
Rituximab‐dose‐adjusted Epoch (r‐da‐epoch) in Primary Mediastinal Large B‐cell Lymphoma (pmlbcl): Real‐life Experience on 190 Patients From 3 Mediterranean Countries
2021 · T. Vassilakopoulos, B. Ferhanoglu, et al. · Hematological Oncology · 4
PDF
Characteristics and outcome of multiple myeloma patients presenting with anaemia only: A retrospective multi-centre study
2020 · Tamir Shragai, Moshe E. Gatt, et al. · Leukemia Research · 4
Real-World Data on Incidence, Clinical Characteristics and Outcome of Patients with Macrofocal Multiple Myeloma (MFMM) in the Era of Novel Therapies: A Study of the Greco-Israeli Collaborative Myeloma Working Group
2018 · Eirini Katodritou, Efstathios Kastritis, et al. · Blood · 3
REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐da‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A MULTINATIONAL ANALYSIS OF 274 PATIENTS
2023 · T. Vassilakopoulos, B. Ferhanoglu, et al. · Hematological Oncology · 2
PDF
Primary Central Nervous System Lymphoma: Clinical Characteristics, Treatment Options and Therapeutic Outcome in 36 Patients. A Single Center Experience.
2022 · Miri Zektser, Anat Rabinovich, et al. · PubMed · 2
Preventing varicella zoster infection in immunocompromised adults with varicella zoster–specific immunoglobulins
2023 · Daniel Gelman, Miri Zektser, et al. · Antimicrobial Stewardship & Healthcare Epidemiology · 1
PDF
Works count: 41
Citation count: 572
H-index: 14
I10-index: 16
Year
Topic
Type